Cidara Therapeutics, Inc.
CDTX
$66.96
$2.834.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 210.63% | 479.47% | 430.56% | 161.73% | 225.93% |
| Total Receivables | -20.86% | -76.73% | -87.96% | -40.49% | -57.16% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 596.20% | 287.78% | 651.52% | 645.85% | -57.24% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -31.63% | -- | -- |
| Total Current Assets | 215.44% | 303.23% | 246.29% | 171.68% | 170.87% |
|
|
|||||
| Total Current Assets | 215.44% | 303.23% | 246.29% | 171.68% | 170.87% |
| Net Property, Plant & Equipment | -47.67% | -43.15% | -22.70% | -8.34% | -0.43% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.65% | -90.27% | -90.84% | 17.95% | -90.20% |
| Total Assets | 208.22% | 263.70% | 220.45% | 155.77% | 154.99% |
|
|
|||||
| Total Accounts Payable | -3.58% | -3.13% | -4.35% | -18.96% | 20.48% |
| Total Accrued Expenses | -20.12% | 22.82% | 18.93% | 145.18% | 163.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.64% | -1.84% | 26.31% | 50.43% | 61.57% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -99.93% |
| Total Other Current Liabilities | -- | -- | -- | -- | -99.93% |
| Total Current Liabilities | -18.48% | -25.40% | -26.50% | 24.48% | 26.17% |
|
|
|||||
| Total Current Liabilities | -18.48% | -25.40% | -26.50% | 24.48% | 26.17% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -69.91% | -61.17% | -45.93% | -28.55% | -22.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -21.85% | -29.01% | -31.57% | -15.75% | -19.31% |
|
|
|||||
| Common Stock & APIC | 72.37% | 78.91% | 78.79% | 56.04% | 56.17% |
| Retained Earnings | -21.64% | -40.50% | -38.47% | -31.74% | -30.48% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 282.76% | 896.86% | 2,089.14% | 1,338.54% | 749.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 282.76% | 896.86% | 2,089.14% | 1,338.54% | 749.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 282.76% | 896.86% | 2,089.14% | 1,338.54% | 749.46% |
|
|
|||||